Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05805319 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dietary Intervention for NSCLC Patients Treated With ICI

StatusUnknown
PhaseNot applicable
Started2023-04-27
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 12, 2024 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2024-08-09
Study Identification, Study Status v3
Trial statusRecruiting→Unknown
2024-08-07
Study Status v2
Re-verified, no change to tracked fields
2023-06-27
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-05-31→confirmed 2023-04-27
Study sitesdetails revised at 1 of 1 site
2023-04-06
Original filing
This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.
Trial Details
NCT Number NCT05805319
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Non Small Cell Lung Cancer
Enrollment 80 participants
Start Date 2023-04-27
Primary Completion 2025-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-12